First flow and second flow signal analysis system based on CRISPR / Cas12a and logic gate

By coupling the CRISPR/Cas12a system with SDA isothermal amplification and logic gate, the complex and cost problems of virus detection methods in the prior art are solved, and efficient specific analysis of the logical signals of current A and current B are realized. Potential application value in disease diagnosis.

CN119082374APending Publication Date: 2024-12-06重庆医科大学国际体外诊断研究院
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411468601.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-21
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing virus detection methods are complex, expensive, and difficult to meet the clinical low-cost detection needs. Especially in multiple target detection, the nonspecific trans cleavage of reporter genes by the CRISPR/Cas system limits its application.

Method used

Coupling the CRISPR/Cas12a system with SDA isothermal amplification and logic gate, accurately cut RNA/DNA heteroduplex through BstNI, convert flow A or flow B RNA into short DNA, and use SDA isothermal nucleic acid amplification to generate input strands , and combine with CRISPR/Cas12a complex to realize the analysis of the logical signals of current A and current B.

Benefits of technology

A simple and universal viral logic signal analysis system is realized, which improves the specificity and efficiency of target recognition, reduces detection costs, is suitable for multiple target detection, and demonstrates its potential application value in disease diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082374A_ABST
    Figure CN119082374A_ABST
Patent Text Reader

Abstract

The invention relates to a first flow and second flow signal analysis system based on CRISPR / Cas12a and a logic gate. According to the invention, a CRISPR / Cas12a system is coupled with SDA isothermal amplification and a logic gate, so that logic identification of the A-flow virus and the B-flow virus is successfully realized. The BstNI precise cutting can realize the transformation of virus RNA, and widens the target detection range. SDA isothermal nucleic acid amplification can provide efficient amplification, complex temperature circulation equipment is not needed, and target signal amplification can be achieved. The CRISPR / Cas12a has high specific recognition capability and can enhance the recognition of a target, and the modular characteristic of the CRISPR / Cas12a increases the capability of linking with other molecular networks. The logic gate achieves logic signal analysis of the first flow and the second flow. Meanwhile, according to the detection strategy provided by the invention, detection of other nucleic acids can be realized only by changing a transformant and an amplified template. Results show that the logic gate biosensor has potential application value in the aspect of disease diagnosis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a biosensor, in particular to a flow A and flow B signal analysis system based on logic gates. Background Art

[0002] Logic gates are binary circuits that can effectively distinguish multiple signals, making them a valuable tool for analyzing complex samples. In the past few years, molecular logic gates, which offer unparalleled advantages by implementing Boolean operations at the molecular scale, have gradually replaced traditional silicon-based electronic computers. To date, DNA biocomputing systems have been successfully fabricated to perform basic, advanced, and complex logic functions, such as keypad locks, encoders, decoders, adders, and subtractors. Despite the great progress, most of them are still underdeveloped in practical applications. For example, in building a logic gate sensing platform for virus detection, Chen et al. developed a dynamic network of tetrahedrons and logic gates for COVID-19 or other coronavirus diagnostic detection. Zuo et al. developed a dual-fragment triggered DNA ladder nanostructure based on logic gates and dispersed to localized catalytic hairpin assembly for fluorescence detection of SARS-CoV-2 and H1N1. Song et al. constructed a photoelectrochemical sensor based on OR logic gates for logical discrimination of high-risk human papillomavirus. Although these designs have been successfully used for target detection, they either require the design of complex nanostructures, or special phototransduction, or are costly and have background leakage. Therefore, it is of great significance to establish a simple, low-cost, and specific virus logic signal analysis system.

[0003] In order to meet this challenge, the present invention relates to a biosensor, and in particular to a CRISPR / Cas12a and logic gate-based flow 1 and flow 2 signal analysis system. Regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) clusters are highly specific and modular for targeted nucleic acid sequences and are innovative tools for molecular diagnosis. Although the CRISPR platform has powerful biosensing functions in terms of detection specificity and sensitivity, the trans-cleavage of reporter genes by the CRISPR / Cas system is non-specific, limiting the application of multiple target detection. Zhang et al. screened out Cas effectors with different preferences for cleavage groups, but the availability of orthogonal Cas effectors limited multiplexing to four targets. Another alternative is to compartmentalize the Cas reaction and run parallel analysis. Pardis C. Sabeti combined droplet fluid technology with CRISPR technology for high-throughput nucleic acid detection. However, the process is cumbersome and requires complex tools to generate, merge and detect individual droplets. Liu uses multiple flow chambers to contain target-specific CRISPR / Cas12a complexes. These methods require the design of different crRNAs for different targets, or complex isolation devices, which are costly and difficult to meet the clinical low-cost detection needs. Boolean logic can be applied to any type of information represented as 0 (NO) and 1 (YES), and is widely used to achieve this qualitative analysis. In the past decade, due to the advantages of DNA such as stability, accessibility and operability, a lot of research work has focused on the design and application of DNA logic gate (DLG)-based biosensors that can realize logic-gated biomedical functions. The emergence of logic gating may improve the ability of CRISPR / Cas12a to analyze multiple targets.

[0004] The present invention couples the CRISPR / Cas12a system with SDA isothermal amplification and logic gates to achieve logical identification of influenza A and B viruses. SDA isothermal nucleic acid amplification can provide efficient amplification without complex temperature cycling equipment and has extremely high amplification efficiency. CRISPR / Cas12a is highly specific and modular, which can enhance the recognition of targets. Logic gates can realize logical signal analysis of influenza A and B. Summary of the invention

[0005] The purpose of the present invention is to develop a simple, universal and specific virus logic signal analysis system.

[0006] The specific technical solutions are as follows:

[0007] A CRISPR / Cas12a and logic gate-based influenza A and influenza B signal analysis system, the preparation method of which comprises the following steps:

[0008] (1) The initial stage of conversion of influenza A and B RNA sequences involves precise cleavage of DNA in RNA / DNA heteroduplexes by BstNI to convert influenza A or B RNA into short DNA. Incubate 8ul of influenza A / B virus RNA and 8ul of 10uM influenza A / B virus DNA transformants at 37 degrees Celsius for 10 minutes. Then add 1.5ul of 10× NEBuffer 3.1, 1.7ul of 10U / ul BstNI and 0.8ul of diethylpyrocarbonate (DEPC) treated water and react at 55 degrees Celsius for 10 minutes to obtain the converted promoter A / B. Store the above converted promoter A / B at 4 degrees Celsius.

[0009] (2) Preparation of input chain The prepared promoter was used for strand displacement isothermal amplification (SDA) to generate the input chain of the downstream logic gate. 10ul of the conversion product, 1ul 10uM template A / B, 1ul 10× Bst DNA Polymerase, 1ul 10× ThermoPol, 1ul 10× Nt.BstNBI, 1ul 10× NEBuffer r3.1, 1ul 10mM dNTP and 4ul pure water were mixed, reacted at 55 degrees Celsius for 30 minutes and then terminated at 80 degrees Celsius for 15 minutes to obtain the input chain InputA / B.

[0010] (3) Preparation of logic gates 1.2ul 10uM crRNA, 1ul 10uM Cas and 22.8 DEPC water were mixed to prepare 400n crRNA-Cas complex. The AND logic gate gating system contains 2ul 400nM crRNA-Cas complex, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. 400nM crRNA-Cas complex and 1uM OR-pre-exsited-R were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 1. 400nM crRNA-Cas complex and 1uM OR-pre-exsited-L were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 2. The OR logic gate gating system contains 1ul pre-complex 1, 1ul pre-complex 2, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L1, 1uM NOR-pre-exsited-R1 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 3. 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L2, 1uM NOR-pre-exsited-R2 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 4. The NOR logic gate gating system contains 1ul pre-complex 3, 1ul pre-complex 4, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. In this way, a flow A and flow B signal analysis system based on logic gates was established.

[0011] (4) Signal output Mix 10ul of Input A / B with 10ul of prepared AND, OR, NOR logic gate gating system solution, react in a ROTOR fluorescence instrument at 37 degrees Celsius for 1 hour, measure the fluorescence signal in the HEX channel, and perform logic signal analysis on flow A and flow B. In step (1), react at 55 degrees Celsius for 10 minutes.

[0012] In the step (2), the reaction is terminated by reacting at 55 degrees Celsius for 30 minutes and then at 80 degrees Celsius for 15 minutes.

[0013] In the step (3), the volume ratio of the crRNA-Cas complex and OR-pre-exsited-R is 2:1 and incubated for 10 minutes to prepare pre-complex 1. 400nM crRNA-Cas complex and 1uM OR-pre-exsited-L are incubated for 10 minutes at a volume ratio of 2:1 to prepare pre-complex 2. The crRNA-Cas complex, NOR-pre-exsited-L1, and NOR-pre-exsited-R1 are incubated for 10 minutes at a volume ratio of 2:1:1 to prepare pre-complex 3. The crRNA-Cas complex, NOR-pre-exsited-L2, and NOR-pre-exsited-R2 are incubated for 10 minutes at a volume ratio of 2:1:1 to prepare pre-complex 4.

[0014] In the step (4), the reaction is carried out at 37 degrees Celsius for 1 hour.

[0015] The present invention establishes a signal analysis system for influenza A and influenza B based on CRISPR / Cas12a and logic gates. The initial stage of its detection principle involves BstNI accurately cutting DNA in RNA / DNA heteroduplexes to convert influenza A or influenza B RNA into short DNA for SDA isothermal amplification. Different conversion DNA can hybridize with RNA sequences of InfluenzaA and Influenza B to form RNA / DNA heteroduplexes with BstNI nuclease recognition sites. Under the action of restriction endonucleases, the transformant DNA releases a short fragment as a promoter for SDA. The promoter then hybridizes with the corresponding SDA amplification template, and the Bst DNA polymerase showing chain displacement activity promotes chain extension. Then dsDNA is cut by Nt.BstNBI at these nick sites to release the downstream input chain. The input chain reacts with the designed CRISPR / Cas12a gate, and when influenza A and influenza B exist at the same time, the AND gate can output a logic signal. When either influenza A or influenza B exists, the OR gate can output a logic signal. When both stream A and stream B do not exist, the NOR gate can output a logic signal.

[0016] The successful preparation of logic gates plays a vital role in the logic biosensor. We first use the synthesized input chain to test whether AND, OR, and NOR gates can generate the correct signal. Figure 1 As shown in the figure, it is a fluorescence curve diagram when the AND logic gate signal is output. When two input signals InputA and InputB exist at the same time, a fluorescence signal will be generated (curve a). When only InputA exists, there is no fluorescence signal (curve b). When only InputB exists, there is no fluorescence signal (curve c). When neither InputA nor InputB exists, there is no fluorescence signal (curve d). As shown in the attached figure, Figure 2As shown in the figure, it is a fluorescence curve diagram when the OR logic gate signal is output. When two input signals InputA and InputB exist at the same time, a fluorescence signal is generated (curve a). When only InputA exists, a fluorescence signal is generated (curve c). When only InputB exists, a fluorescence signal is generated (curve b). When neither InputA nor InputB exists, there is no fluorescence signal (curve d). As shown in the attached figure, Figure 3 As shown in the figure, it is a fluorescence curve diagram when the NOR logic gate signal is output. When both input signals InputA and InputB exist at the same time, there is no fluorescence signal (curve c). When only InputA exists, there is no fluorescence signal (curve b). When only InputB exists, there is no fluorescence signal (curve d). When neither InputA nor InputB exists, a fluorescence signal is generated (curve a). These results all show that the logic gate control system has been successfully constructed.

[0017] We then demonstrated that BstNI can precisely cleave DNA in RNA / DNA heteroduplexes to convert either influenza A or influenza B RNA into short DNA fragments. Figure 4 As shown, the PAGE diagram shows the results of enzyme digestion. Lane 1 is influenza A RNA, Lane 2 is influenza A converter Convertor A, and Lane 3 is the complex of influenza A RNA and Convertor A. Lane 4 is the band after enzyme digestion, Lane 5 is the result without adding enzyme, and Lane 6 is the object of Inititor-A. These results show that influenza A RNA successfully converted DNA promoter A. Lane 7 is influenza B RNA, Lane 8 is converter Convertor B, Lane 9 is the complex of influenza B RNA and Convertor B, Lane 10 is the product after enzyme digestion, Lane 11 is the product without adding enzyme, and Lane 12 is the object of Inititor-B. These results show that influenza B RNA successfully converted DNA promoter B.

[0018] Next, we used the above-transformed promoter for SDA amplification to generate the input strand. Figure 5 As shown, the results of the input chain required for AND and OR logic gates are displayed. Lane 1 is Inititor-A, Lane 2 is Template A, Lane 3 is the complex of Inititor-A and Template A, Lane 4 is the result of positive amplification, Lane 5 is negative amplification, and Lane 6 is the reference of Input1. These results show that the promoter transformed by influenza A successfully amplified the input chain A. Lane 7 is Inititor-B, Lane 8 is Template B, Lane 9 is the complex of Inititor-B and Template B, Lane 10 is the result of positive amplification, Lane 11 is negative amplification, and Lane 12 is the reference of Input2. These results show that the promoter transformed by influenza B successfully amplified the input chain B. As shown in the attached Figure 6As shown, the results of the input chain required for the NOR logic gate are displayed. Lane 1 is inititor-A, lane 2 is template A, lane 3 is the complex of Inititor-A and template A, lane 4 is the result of positive amplification, lane 5 is negative amplification, and lane 6 is the reference of input1. These results show that the promoter transformed by influenza A successfully amplified the input chain A. Lane 7 is Inititor-B, lane 8 is template B, lane 9 is the complex of inititor-B and template B, lane 10 is the result of positive amplification, lane 11 is negative amplification, and lane 12 is the reference of Input2. These results show that the promoter transformed by influenza B successfully amplified the input chain B.

[0019] Finally, we need to analyze the logic of the signal. We add the input chains generated above to the logic gating system to verify the output of the final signal. Figure 7 As shown in the figure, it is a fluorescence bar graph when the AND logic gate signal is output. When both influenza A and influenza B exist at the same time, a signal is generated after conversion, amplification, and input (bar graph c). When only influenza A exists, there is no signal (bar graph a). When only influenza B exists, there is no signal (bar graph b). When neither influenza A nor influenza B exists, there is no signal (bar graph d). As shown in the attached figure, Figure 8 As shown in the figure, it is a fluorescence bar graph when the OR logic gate signal is output. When both influenza A and influenza B exist at the same time, a signal is generated after conversion, amplification, and input (bar graph a). When only influenza A exists, there is a signal (bar graph b). When only influenza B exists, there is a signal (bar graph c). When neither influenza A nor influenza B exists, there is no signal (bar graph d). As shown in the attached figure, Fig. 9 As shown, it is a fluorescence bar graph when the NOR logic gate signal is output. When both influenza A and influenza B are present, there is no signal after conversion, amplification, and input (bar graph a). When only influenza A is present, there is no signal (bar graph b). When only influenza B is present, there is no signal (bar graph c). When influenza A and influenza B are not present, a signal is generated (bar graph d). The above results demonstrate the feasibility of the CRISPR / Cas12a logic gating system for analyzing influenza A and influenza B.

[0020] The present invention couples the CRISPR / Cas12a system with SDA isothermal amplification and logic gates, and successfully realizes the logical identification of influenza A and influenza B viruses. BstNI precise cutting can realize RNA conversion and broaden the target detection range. SDA isothermal nucleic acid amplification can provide efficient amplification, without the need for complex temperature cycling equipment, and can achieve target signal amplification. CRISPR / Cas12a has highly specific recognition capabilities, which can enhance the recognition of targets, and its modular characteristics increase the ability to connect with other molecular networks. Logic gates realize logical signal analysis of influenza A and influenza B. At the same time, the detection strategy we proposed only needs to change the converter and the amplified template to realize the detection of other nucleic acids. The results show that the logic gate biosensor has potential application value in disease diagnosis. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 It is the fluorescence curve graph of AND logic gate verification.

[0022] Figure 2 It is the fluorescence curve diagram of OR logic gate verification.

[0023] Figure 3 It is the fluorescence curve diagram of NOR logic gate verification.

[0024] Figure 4 This is a PAGE diagram of influenza A and B RNA after conversion enzyme digestion.

[0025] Figure 5 It is the PAGE representation of the input chain generated by the AND / OR logic gate SDA.

[0026] Figure 6 It is the PAGE representation of the input chain generated by the NOR logic gate SDA.

[0027] Figure 7 is a fluorescent bar graph of an AND logic gate.

[0028] Figure 8 is the fluorescent bar graph of the OR logic gate.

[0029] Fig. 9 is a fluorescent bar graph of a NOR logic gate. DETAILED DESCRIPTION

[0030] A CRISPR / Cas12a and logic gate-based influenza A and influenza B signal analysis system, the preparation method of which comprises the following steps:

[0031] (1) The initial stage of conversion of influenza A and B RNA sequences involves precise cleavage of DNA in RNA / DNA heteroduplexes by BstNI to convert influenza A or B RNA into short DNA. Incubate 8ul of influenza A / B virus RNA and 8ul of 10uM influenza A / B virus DNA transformants at 37 degrees Celsius for 10 minutes. Then add 1.5ul of 10× NEBuffer 3.1, 1.7ul of 10U / ul BstNI and 0.8ul of diethylpyrocarbonate (DEPC) treated water and react at 55 degrees Celsius for 10 minutes to obtain the converted promoter A / B. Store the above converted promoter A / B at 4 degrees Celsius.

[0032] (2) Preparation of input chain The prepared promoter was used for strand displacement isothermal amplification (SDA) to generate the input chain of the downstream logic gate. 10ul of the conversion product, 1ul 10uM template A / B, 1ul 10× Bst DNA Polymerase, 1ul 10× ThermoPol, 1ul 10× Nt.BstNBI, 1ul 10× NEBuffer r3.1, 1ul 10mM dNTP and 4ul pure water were mixed, reacted at 55 degrees Celsius for 30 minutes and then terminated at 80 degrees Celsius for 15 minutes to obtain the input chain InputA / B.

[0033] (3) Preparation of logic gates 1.2ul 10uM crRNA, 1ul 10uM Cas and 22.8 DEPC water were mixed to prepare 400n crRNA-Cas complex. The AND logic gate gating system contains 2ul 400nM crRNA-Cas complex, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. 400nM crRNA-Cas complex and 1uM OR-pre-exsited-R were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 1. 400nM crRNA-Cas complex and 1uM OR-pre-exsited-L were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 2. The OR logic gate gating system contains 1ul pre-complex 1, 1ul pre-complex 2, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L1, 1uM NOR-pre-exsited-R1 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 3. 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L2, 1uM NOR-pre-exsited-R2 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 4. The NOR logic gate gating system contains 1ul pre-complex 3, 1ul pre-complex 4, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water. In this way, a flow A and flow B signal analysis system based on logic gates was established.

[0034] (4) Signal Output Mix 10ul of Input A / B with 10ul of prepared AND, OR, and NOR logic gate gating system solution, react in a ROTOR fluorescence instrument at 37 degrees Celsius for 1 hour, measure the fluorescence signal in the HEX channel, and perform logic signal analysis on flow A and flow B.

Claims

1. A CRISPR / Cas12a and logic gate-based influenza A and influenza B signal analysis system, the preparation method of which comprises the following steps: (1) Influenza A and B RNA sequence conversion The initial stage involves precise cleavage of DNA in RNA / DNA heteroduplexes by BstNI to convert influenza A or B RNA into short DNA; 8ul of influenza A / B virus RNA and 8ul of 10uM influenza A / B virus DNA transformants are incubated at 37 degrees Celsius for 10 minutes; then 1.5ul of 10× NEBuffer 3.1, 1.7ul of 10U / ul of BstNI and 0.8ul of diethylpyrocarbonate (DEPC) treated water are added to react at 55 degrees Celsius for 10 minutes to obtain the transformed promoter A / B; the above transformed promoter A / B is stored at 4 degrees Celsius; (2) Preparation of input chain The prepared promoter was used for strand displacement isothermal amplification (SDA) to generate the input chain of the downstream logic gate; 10ul of the conversion product, 1ul10uM template A / B, 1ul 10× BstDNAPolymerase, 1ul 10× ThermoPol, 1ul 10× Nt.BstNBI, 1ul 10× NEBuffer r3.1, 1ul 10mM dNTP and 4ul pure water were mixed, reacted at 55 degrees Celsius for 30 minutes and then terminated at 80 degrees Celsius for 15 minutes to obtain the input chain InputA / B; (3) Preparation of logic gates 1.2ul 10uM crRNA, 1ul 10uM Cas and 22.8 DEPC water were mixed to prepare 400n crRNA-Cas complex; the AND logic gate gating system contained 2ul400nM crRNA-Cas complex, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water; 400nM crRNA-Cas complex and 1uM OR-pre-exsited-R were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 1; 400nM crRNA-Cas complex and 1uM OR-pre-exsited-L were incubated at a volume ratio of 2:1 for 10min to prepare pre-complex 2; the OR logic gate gating system contained 1ul pre-complex 1, 1ul pre-complex 2, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water; 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L1, 1uM NOR-pre-exsited-R1 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 3; 800nM crRNA-Cas complex, 1uM NOR-pre-exsited-L2, 1uM NOR-pre-exsited-R2 were incubated at a volume ratio of 2:1:1 for 10min to prepare pre-complex 4; the NOR logic gate gating system contained 1ul pre-complex 3, 1ul pre-complex 4, 2ul 10× Cutsmart buffer, 1ul 5uM HEX reporter gene, 2ul 10mM DTT solution and 3ul DEPC water; thus, a flow A and flow B signal analysis system based on logic gates was established; (4) Signal output Mix 10ul of Input A / B with 10ul of prepared AND, OR, NOR logic gate gating system solution, react in a ROTOR fluorescence instrument at 37 degrees Celsius for 1 hour, measure the fluorescence signal in the HEX channel, and perform logic signal analysis on flow A and flow B.

2. The logic gate-based influenza A and influenza B signal analysis system as claimed in claim 1, wherein the preparation method comprises reacting at 55 degrees Celsius for 10 minutes in step (1).

3. The logic gate-based influenza A and influenza B signal analysis system as claimed in claim 1, wherein in step (2) of the preparation method, the reaction is carried out at 55 degrees Celsius for 30 minutes and then at 80 degrees Celsius for 15 minutes to terminate the reaction.

4. The logic gate-based influenza A and influenza B signal analysis system as described in claim 1, wherein in step (3) of the preparation method, the volume ratio of the crRNA-Cas complex and OR-pre-exsited-R is 2:1 and incubated for 10 minutes to prepare pre-complex 1; 400nM crRNA-Cas complex and 1uM OR-pre-exsited-L are incubated for 10 minutes in a volume ratio of 2:1 to prepare pre-complex 2; crRNA-Cas complex, NOR-pre-exsited-L1, NOR-pre-exsited-R1 are incubated for 10 minutes in a volume ratio of 2:1:1 to prepare pre-complex 3; crRNA-Cas complex, NOR-pre-exsited-L2, NOR-pre-exsited-R2 are incubated for 10 minutes in a volume ratio of 2:1:1 to prepare pre-complex 4.

5. The logic gate-based influenza A and influenza B signal analysis system as claimed in claim 1, wherein the reaction is carried out at 37 degrees Celsius for 1 hour in step (4) of the preparation method.